In MASLD, the increased activation of JNK leads to inhibitory phosphorylation of insulin receptor substrate 1, resulting in insulin resistance and hyperinsulinemia (26). Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.